US55083R1041 - Common Stock
LYELL IMMUNOPHARMA INC
NASDAQ:LYEL (5/15/2024, 5:52:52 PM)
After market: 2.61 0 (0%)2.61
+0.07 (+2.76%)
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company is headquartered in South San Francisco, California and currently employs 274 full-time employees. The company went IPO on 2021-06-17. The technologies powering its product candidates are designed to address barriers that limit consistent and long-lasting responses to cell therapy for solid tumors: T-cell exhaustion and lack of durable stemness, which includes the ability to persist and self-renew to drive durable tumor cytotoxicity. The Company’s technologies are designed to generate T cells with the ability to persist and self renew while driving durable tumor cytotoxicity, even in the setting of an immunosuppressive tumor microenvironment. Its technologies can be applied in a target agnostic manner to multiple T cell modalities, including chimeric antigen receptor (CAR), tumor-infiltrating lymphocytes (TIL) and T cell receptor (TCR) therapies. Its product candidates include LYL797, LYL845 and LYL119. The LYL119 is a ROR1 CAR T-cell product designed for enhanced cytotoxicity.
LYELL IMMUNOPHARMA INC
201 Haskins Way, Suite 301
South San Francisco CALIFORNIA
P: 16506950677
CEO: Elizabeth Homans
Employees: 274
Website: https://lyell.com/
SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company...
LYEL stock results show that Lyell Immunopharma beat analyst estimates for earnings per share the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Lyell Immunopharma (NASDAQ:LYEL) just reported results for the first quarter of...
Expect to share initial clinical and translational data from the Phase 1 trial of LYL797, a ROR1-targeted CAR T‑cell product candidate, this quarterOn...
Here you can normally see the latest stock twits on LYEL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: